Press Releases

Press Releases

PDL BioPharma, Inc. today announced that it has entered into a credit agreement with CareView Communications, Inc. (OTCQB: CRVW) whereby PDL will provide CareView with up to $40 million of secured debt financing. CareView is an information technology provider to the healthcare industry focused on patient care monitoring. Under the…

Press Releases

PharmaVentures is pleased to announce that it has acted as advisor to Chip-Man Technologies Oy (CMT) on its divestment of certain assets to Yokogawa Electric Corporation (Yokogawa). The assets relate to CMTs world leading capabilities in cellular imaging and analysis. This transaction is the latest in a series of successful…

Press Releases

BioClinica®, Inc., the world's leading specialty clinical trial service provider, announced today the opening of new and expanded offices in London and Munich to better serve its growing client base in Europe. The state-of-the-art facilities will offer an array of clinical trial services including medical imaging, site training and support,…

Press Releases

Spinifex Pharmaceuticals, Inc. and its Australian subsidiary Spinifex Pharmaceuticals Pty Ltd (“Spinifex”), a company focused on the development of new drugs for the treatment of chronic pain, today announced agreement to the sale of Spinifex to Novartis International AG (“Novartis”), for an upfront cash consideration of US$200 million plus significant…

Press Releases

Tabuk Pharmaceutical Manufacturing Company has announced plans to increase its female employee intake in the next 5 years; by hiring 200-300 additional females in Tabuk, Riyadh and Dammam to increase their share of the total headcount to 20%. Tabuk's commitment to the employment of Saudi females is aligned with an…

Press Releases

Teva Pharmaceutical Industries Ltd. and Active Biotech today announced that the patient enrollment for the pivotal Phase III CONCERTO trial has been finalized, as well as a planned sample size re-assessment analysis of the study. CONCERTO, the third Phase III trial of laquinimod in patients with relapsing-remitting multiple sclerosis (RRMS),…

Press Releases

BioBlast Pharma Ltd., a clinical-stage orphan disease-focused biotechnology company, announced today that it has been granted Orphan Drug Designation by the European Commission for Cabaletta for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD). BioBlast is starting a double-blind, placebo-controlled Phase 3 pivotal study across multiple clinical centers in the US…

Press Releases

Rite Aid has completed its previously announced acquisition of Envision Pharmaceutical Services (“EnvisionRx”) from leading global private investment firm TPG and other shareholders in a transaction valued at approximately $2 billion, including approximately $1.8 billion in cash and approximately 27.9 million Rite Aid shares. “As part of Rite Aid, we…

Press Releases

Moberg Pharma AB today announced that a grant of EUR 0.9 million in public funding has been approved by Eurostars for a project proposal related to late-stage development of Moberg Pharma’s BUPI project. The Eurostars project “BUPI - a long-acting lozenge with bupivacaine for pain relief of Oral Mucositis in…

Press Releases

ESSA Pharma Inc. announced today that it has appointed Dr. David Parkinson to its board of directors. Dr. Parkinson's appointment as an independent director is effective immediately. "We are delighted to have David join our board," stated Richard Glickman, Chairman of the ESSA board of directors.  "With his extensive background…